Vipin Shankar Chelakkot, Ph.D

2007-2008 Chemistry Vellore institute of Technology 
 2008-2010 Biochemistry Muhimbili University 
 2010-2015 Pediatrics Mie University Graduate School of Medicine 
 2015- Division of BioMedical Sciences Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada 
Cancer Biology, Photodynamic Therapy
"Vipin Shankar Chelakkot"


Sign in to add mentor
Mary Saral research assistant 2007-2008 Vellore institute of Technology (Neurotree)
Hiroki Hori grad student 2010-2015 Mie University Graduate School of Medicine (Neurotree)
Kensuke Hirasawa post-doc 2015- MUN (Neurotree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chelakkot VS, Som J, Yoshioka E, et al. (2019) Systemic MEK inhibition enhances the efficacy of 5-aminolevulinic acid-photodynamic therapy. British Journal of Cancer
Yoshioka E, Chelakkot VS, Licursi M, et al. (2018) Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway. Theranostics. 8: 2134-2146
Xu DQ, Toyoda H, Yuan XJ, et al. (2018) Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo. Experimental Cell Research
Vazhappilly Cijo George, Shabbir Ansari, Vipin Shankar Chelakkot, et al. (2018) DNA-dependent protein kinase: Epigenetic alterations and the role in genomic stability of cancer Mutation Research/Reviews in Mutation Research. 130-8
Vipin Shankar, Hiroki Hori, Kentaro Kihira, et al. (2016) Mesenchymal Stromal Cell Secretome Up-Regulates 47 kDa CXCR4 Expression, and Induce Invasiveness in Neuroblastoma Cell Lines Plos One
Qi L, Toyoda H, Shankar V, et al. (2013) Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses. Cancer Science. 1162-71
See more...